Latazed (Latanoprost)

Latanoprost mimics prostaglandin F2α and binds to FP receptors in the ciliary body. This triggers remodeling of the extracellular matrix, increasing uveoscleral outflow of aqueous humor, which lowers intra‑ocular pressure and reduces the risk of glaucomatous damage.

The dosing regimen for Latazed is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing must follow the prescriber’s instructions.

The safety of latanoprost in pregnancy and lactation has not been established. It is classified as pregnancy category unknown, and use is generally avoided unless the potential benefit outweighs the risk, as decided by the healthcare provider.

To request Latazed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Latazed (latanoprost) belongs to the prostaglandin analog class, which typically offers once‑daily dosing and a favorable efficacy profile compared with beta‑blocker or carbonic anhydrase inhibitor drops. It often provides greater pressure reduction and a different side‑effect spectrum, such as iris pigmentation changes.

Latazed should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from light, moisture and extreme temperatures to maintain potency. Do not freeze the product.

Latazed is applied as an ophthalmic solution. The patient places a single drop into the prescribed eye(s) once daily, preferably in the evening, avoiding contact with the tip of the bottle. Hands should be washed before and after application.

Although uncommon, serious adverse events can include uveitis and severe allergic reactions such as swelling, rash or anaphylaxis. Patients should seek immediate medical attention if they experience significant eye pain, redness, vision changes, or systemic allergic symptoms.

Latazed is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. It should also be avoided in eyes with active intra‑ocular inflammation, infection, or in individuals with a history of severe ocular irritation from prostaglandin analogs.